Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
We report alterations to the murine leukemia virus (MLV) integrase (IN) protein that successfully result in decreasing its integration frequency at transcription start sites and CpG islands, thereby reducing the potential for insertional activation. The host bromo and extraterminal (BET) proteins Brd2, 3 and 4 interact with the MLV IN protein primarily through the BET protein ET domain. Using solution NMR, protein interaction studies, and next generation sequencing, we show that the C-terminal tail peptide region of MLV IN is important for the interaction with BET proteins and that disruption of this interaction through truncation mutations affects the global targeting profile of MLV vectors. The use of the unstructured tails of gammaretroviral INs to direct association with complexes at active promoters parallels that used by histones and RNA polymerase II. Viruses bearing MLV IN C-terminal truncations can provide new avenues to improve the safety profile of gammaretroviral vectors for human gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. NMR analysis of MLV IN: Brd3 ET interaction. A. MLV IN CTD sequence is displayed with the following color codes: green indicates backbone amide resonance chemical shifts that were the same for IN CTD in the presence or absence of Brd3 ET at pH 8.0; red indicates backbone amide resonances that are observed in the presence of Brd3 ET, but solvent exchange broadened in the absence of complex formation, and/or amide resonances that exhibit frequency shifts upon complex formation; blue indicates backbone amide resonance assignments that could not be determined at pH 8.0 either in the presence or absence of the Brd3 ET domain. Residues for which HN amide assignments could not be determined in either free or ET-bound CTD at pH 8.0 include R337, H338, T340, K341, N342, R346, W347, A367, S385, S386, Q396, as well as proline residues P345, P350, P358, P380, P384, P398 and P408 which lack amide protons. B. Cα backbone trace, along with key structural features, of an ensemble of 20 conformers of MLV IN CTD from amino acids 329–408 (PDB ID 2M9U) is shown in this panel with the same color codes as described in panel A. C. Ribbon representation of a single MLV IN CTD conformer is shown within a transparent view of a surface space fill model. Color code is the same as in panel A with key structural features and specific amino-acid residues that show significant CSPs and/or reduced amide proton exchange broadening marked in red. All images were generated using PyMol (The PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC.) D. NMR spectrum of the IN CTD–Brd3 ET complex. Overlay of [15N−1H]-HSQC spectra of 15N-enriched IN CTD construct IN329–408 at pH 8.0, 300 mM NaCl either with (blue) or without (red) unlabeled Brd3ET. The stoichiometric ratio of IN329–408 (1 mM) and Brd3 ET (2 mM) was 1:2 at the concentrations indicated. Backbone amide resonances that are not affected by complex formation are labeled with sequence-specific assignments in black; assigned amide resonances that are not observable due to solvent-exchange broadening in the absence of ET, but become observable upon complex formation, as well as resonances exhibiting significant CSPs upon complex formation are labeled in magenta. All amide peak resonances not observable due to solvent-exchange broadening in the absence of ET, but become observable upon complex formation are marked with black circles; some of these could not be unambiguously assigned at pH 8.0. The curved green arrows indicate the CSPs due to complex formation of the amide resonances assigned to residues L399, L403, A407 and the side-chain indole NHϵ resonance of W390. Tryptophan W347 and W369 NHϵ side chain indole resonances with significant proton exchange rate reduction due to complex formation are also indicated. Peak resonances labeled in green are assigned to the non-cleavable affinity tag.](https://figures.cochat.ai/paper-figures/000fcaa623f843819c678f15da46cf1f/altering-murine-leukemia-virus-integration-through-disruption-of-the-integrase-figure-1.jpg)

![Figure 3. Mutating the consensus TP sequence inhibits interaction of MLV IN CTD with Brd3 ET. A. The 24-residue WT TP sequence is displayed on top and the mutant TP sequence is displayed on bottom. Underlined residues indicate amino-acid residues mutated to alanine. B. Comparison of [15N-1H]-HSQC spectra of the complex formed between 15N-enriched IN CTD (construct IN329–408) and unlabeled Brd3 ET in the presence of the WT TP (blue) and the free 15N-enriched IN CTD (construct IN329–408) spectra (red; same as Supplementary Figure S1B). The stoichiometric ratio of IN329–408 (200 μM) and Brd3 ET (200 μM) was 1:1 and the peptide was added at 3-fold molar excess (600 μM). Under these conditions, the WT TP disrupts the complex by binding to the ET domain, resulting in a spectrum for CTD that is different from that of the complex, but essentially identical to that of free IN CTD. C. Comparison of [15N-1H]-HSQC spectra of 15N-enriched IN CTD (construct IN329–408) and unlabeled Brd3 ET in the presence (red) or absence (blue) of the mutant TP. The stoichiometric ratio of IN329–408 (200 μM) and Brd3 ET (200 μM) was 1:1 and the mutant peptide was added at 3-fold excess (600 μM). The mutant TP does not disrupt the complex, and the spectrum is not changed when the peptide is added. In both panels, backbone amide resonances are labeled in black and peak resonances labeled in magenta are assigned to the non-cleavable affinity tag. Buffer conditions are as follows—buffer 1: 25 mM sodium phosphate pH 8.0, 300 mM NaCl, 50 mM potassium glutamate, 5 mM 2-mercaptoethanol. Buffer 2: 25 mM sodium phosphate pH 8.0, 360 mM NaCl, 60 mM potassium glutamate, 6 mM 2-mercaptoethanol.](https://figures.cochat.ai/paper-figures/8ff778ce1f8d454386125fde57026854/altering-murine-leukemia-virus-integration-through-disruption-of-the-integrase-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While LEDGF/p75 interacts primarily with the lentiviral IN CCD dimer interface, BET proteins more simply engage a conserved linear sequence motif located at the C-terminus of γ-retroviral IN proteins114–116,121.”
From Structure and function of retroviral integrase (2022) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965 · cited 2×
“NMR data were processed using NMRPipe (24) and SPARKY (T.”
MethodChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587 · cited 1×
“However, despite the efficiency in gene delivery, insertional mutagenesis can result in clonal expansion of cells bearing specific integrants (2), associated with the preferential integration of murine leukemia virus (MLV) vectors upstream of transcription start sites (TSS) and CpG islands near promoter regions (3).”
BackgroundTaverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,418
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 2×
“However, despite the efficiency in gene delivery, insertional mutagenesis can result in clonal expansion of cells bearing specific integrants (2), associated with the preferential integration of murine leukemia virus (MLV) vectors upstream of transcription start sites (TSS) and CpG islands near promoter regions (3).”
BackgroundA role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658 · cited 1×
“Datasets used in the analysis: the inset box defines the data sets used in the analysis; FV fibroblast (21), HIV1 (22), MLV ((5) and this work), WT MLV IN1–408, MLV IN1–385 8N, MLV IN1–385 16H, MLV IN1–385 XN (in6215a (11), (Supplementary Table S4).”
MethodSelf-citationHIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer
Engelman, A., Mizuuchi, K., & Craigie, R. (1991) · Cell · doi:10.1016/0092-8674(91)90297-c · Cited by 655 · cited 1×
“nucleus, mediates the integration of the viral DNA into the host genome (6).”
BackgroundDynamic interactions between transposable elements and their hosts
Levin, H. L., & Moran, J. V. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3030 · Cited by 621 · cited 1×
“For Tf1, it is known that a chromodomain at the C-terminus interacts with the host Atf1 protein to drive integration into genes associated with environmental stresses (47).”
BackgroundRahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., & Howley, P. M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01341-10 · Cited by 532 · cited 1×
“Recent studies have identified NSD3, JMJD6, CHD4, GLTSCR1 and ATAD5 proteins as binding partners to the BET family members ET domain (48) and thus the ET domain functions to recruit specific effector proteins to regulate transcriptional activity.”
BackgroundShun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467
Cited by
Lesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy
Wang, Z.-Q., Zhang, Z.-C., Wu, Y.-Y., Pi, Y.-N., Lou, S.-H., Liu, T.-B., Lou, G., & Yang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01647-6 · Cited by 216
Hindmarsh, P., & Leis, J. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.836-843.1999 · Cited by 202
Molecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
Self-citationGogol-Döring, A., Ammar, I., Gupta, S., Bunse, M., Miskey, C., Chen, W., Uckert, W., Schulz, T. F., Izsvák, Z., & Ivics, Z. (2016) · Molecular Therapy · doi:10.1038/mt.2016.11 · Cited by 160
Structure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Host factors for retroviral integration site selection
Debyser, Z., Christ, F., Rijck, J. D., & Gijsbers, R. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.12.001 · Cited by 104
BET proteins: Biological functions and therapeutic interventions
Guo, J., Zheng, Q., & Peng, Y. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108354 · Cited by 98
Interactions between Retroviruses and the Host Cell Genome
Poletti, V., & Mavilio, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.10.001 · Cited by 76
“Solution NMR and protein interaction studies showed that the unstructured C-terminal polypeptide (TP) domain of the MLV IN directly binds the BET ET domain and acquires a secondary structure upon complex formation.(96) Deletion of the TP domain does not disrupt the catalytic properties of IN but widely alters the MLV…”
BackgroundStructural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4
Zhang, Q., Zeng, L., Shen, C., Ju, Y., Konuma, T., Zhao, C., Vakoc, C. R., & Zhou, M.-M. (2016) · Structure · doi:10.1016/j.str.2016.04.019 · Cited by 76
“While the structural basis of BRD4 ET domain binding to murine leukemia virus (MLV) integrase, required for viral/host integration (Aiyer et al., 2014; Larue et al., 2014), was recently reported (Crowe et al.”
Crowe, B. L., Larue, R. C., Yuan, C., Hess, S., Kvaratskhelia, M., & Foster, M. P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516813113 · Cited by 83
“1B, yellow) (12, 23), and NMR studies of the MLV IN C-terminal domain revealed that this region is unstructured, suggesting a “fly-casting” mechanism for BET protein binding (23).”
BackgroundSelf-citationWai, D. C. C., Szyszka, T. N., Campbell, A. E., Kwong, C., Wilkinson‐White, L. E., Silva, A. P. G., Low, J. K. K., Kwan, A. H., Gamsjaeger, R., Chalmers, J. D., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000678 · Cited by 73
“a peptide from MLV-IN that is known to bind the ET domain of Brd4 (50), as well as related sequences found in INO80B, BRG1, NSD3, GLTSCR1, and TAF7.”
BackgroundDemeulemeester, J., De Rijck, J., Gijsbers, R., & Debyser, Z. (2015) · BioEssays · doi:10.1002/bies.201500051 · Cited by 71
Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
Serrao, E., Cherepanov, P., & Engelman, A. N. (2016) · Journal of Visualized Experiments · doi:10.3791/53840 · Cited by 53
Key determinants of target DNA recognition by retroviral intasomes
Serrao, E., Ballandras-Colas, A., Cherepanov, P., Maertens, G. N., & Engelman, A. N. (2015) · Retrovirology · doi:10.1186/s12977-015-0167-3 · Cited by 62
“The amino acid sequence of the IN C-terminal region, WxφxxpxxPLbφbφR (x, non-conserved position; φ, small hydrophobic; p, small polar; b, basic), which dictates binding to BET proteins [29,69,70], is a conserved feature of gammaretroviral IN proteins including Rev-A IN [18].”
BackgroundGenetic Modification of T Cells
Morgan, R. A., & Boyerinas, B. (2016) · Biomedicines · doi:10.3390/biomedicines4020009 · Cited by 57
“Additional studies have demonstrated that truncation of the MLV integrase so that it no longer associates with BET proteins functions to alter the MLV integration profile and significantly reduces the preference for transcriptional start sites near oncogenes [16,17].”
Modulation of chromatin structure by the FACT histone chaperone complex regulates HIV-1 integration
Matysiak, J., Lesbats, P., Mauro, E., Lapaillerie, D., Dupuy, J., Lopez, A. P., Benleulmi, M. S., Calmels, C., Andréola, M., Ruff, M., et al. (2017) · Retrovirology · doi:10.1186/s12977-017-0363-4 · Cited by 49
Intasome architecture and chromatin density modulate retroviral integration into nucleosome
Benleulmi, M. S., Matysiak, J., Henriquez, D. R., Vaillant, C., Lesbats, P., Calmels, C., Naughtin, M., Leon, O., Skalka, A. M., Ruff, M., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0145-9 · Cited by 47
“Recently it has been shown that dissociating the interaction between MLV integrase and BET proteins did not change the local integration site sequence selection [37].”
BackgroundWolff, J. H., & Mikkelsen, J. G. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00865-4 · Cited by 48
“In the case of MLV, the bromodomain and extra-terminal (BET) family of proteins has been shown to interact with the virally encoded integrase [21, 22].”
BackgroundStrategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
Yoder, K. E., Rabe, A. J., Fishel, R. A., & Larue, R. C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.662331 · Cited by 41
Self-citationAlpharetroviral Vectors: From a Cancer-Causing Agent to a Useful Tool for Human Gene Therapy
Suerth, J. D., Labenski, V., & Schambach, A. (2014) · Viruses · doi:10.3390/v6124811 · Cited by 39
“There have been attempts to modify retroviral vectors and/or their tethering factors with the aim to obtain potentially safer integration characteristics [50–56].”
BackgroundMondal, A., Swapna, G. V. T., López, M. M., Klang, L., Hao, J., Ma, L.-C., Roth, M. J., Montelione, G. T., & Pérez, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01595 · Cited by 39
Self-citationSites of retroviral DNA integration: From basic research to clinical applications
Serrao, E., & Engelman, A. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1102859 · Cited by 36
“…BET-mediated bimodal tethering underlying the characteristic predilection of these viruses to integrate adjacent to promoter-associated annotations (Aiyer et al., 2014; De Rijck et al., 2013; El Ashkar et al., 2014; Gupta et al., 2013; Larue et al., 2014; Serrao et al., 2015; Sharma et al.,…”
BackgroundMethodInfluentialAiyer, S., Swapna, G. V. T., Ma, L.-C., Liu, G., Hao, J., Chalmers, G., Jacobs, B. C., Montelione, G. T., & Roth, M. J. (2021) · Structure · doi:10.1016/j.str.2021.01.010 · Cited by 35
Self-citationHotspots of MLV integration in the hematopoietic tumor genome
Tsuruyama, T., Hiratsuka, T., & Yamada, N. (2016) · Oncogene · doi:10.1038/onc.2016.285 · Cited by 32
Ciuffi, A. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.02.013 · Cited by 27
“org/lice in driving fine integration site selection [33,42–45].”
BackgroundCommon Viral Integration Sites Identified in Avian Leukosis Virus-Induced B-Cell Lymphomas
Justice, J., Morgan, R. W., & BEEMON, K. L. (2015) · mBio · doi:10.1128/mbio.01863-15 · Cited by 27
The FACT Complex Promotes Avian Leukosis Virus DNA Integration
Winans, S., Larue, R. C., Abraham, C. M., Shkriabai, N., Skopp, A., Winkler, D., Kvaratskhelia, M., & Beemon, K. L. (2017) · Journal of Virology · doi:10.1128/jvi.00082-17 · Cited by 26
Self-citationStructural and sequencing analysis of local target DNA recognition by MLV integrase
Aiyer, S., Rossi, P., Malani, N., Schneider, W. M., Chandar, A., Bushman, F. D., Montelione, G. T., & Roth, M. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv410 · Cited by 25
“These reduced propensities for integration near TSS and CpG islands, however, do not parallel the effect observed in the MLV IN C mutant that affects the BET protein-IN interaction (12) (Supplementary Figure S7B).”
BackgroundMethodInfluentialSelf-citationEspinoza, J. L., Phillips, A., Prentice, M. B., Tan, G. S., Kamath, P. L., Lloyd, K. G., & Dupont, C. L. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae528 · Cited by 25
“This interaction provides a structural basis for global in vivo integration-site preferences and disruption of this interaction through truncation mutations affects the global targeting profile of MLV ( 186 ).”
BackgroundRibosome profiling of the retrovirus murine leukemia virus
Irigoyen, N., Dinan, A. M., Brierley, I., & Firth, A. E. (2018) · Retrovirology · doi:10.1186/s12977-018-0394-5 · Cited by 25
“regions; the latter of which encompasses the C-terminal tail of the integrase [33] and is included in 187”
BackgroundRetroviral integrase: Structure, mechanism, and inhibition
Passos, D. O., Li, M., Craigie, R., & Lyumkis, D. (2021) · The Enzymes · doi:10.1016/bs.enz.2021.06.007 · Cited by 23
“The bromodomain and extraterminal domain (BET) proteins were shown to preferentially bind gammaretroviral INs [126] and to direct integration to regions upstream of transcription start sites [127-130].”
BackgroundRepurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Xue, Y., Mei, H., Chen, Y., Griffin, J. D., Liu, Q., Weisberg, E., & Yang, J. C. (2023) · MedComm · doi:10.1002/mco2.254 · Cited by 21
An ELISA-Based Screening Platform for Ligand–Receptor Discovery
Ozgul, S., von Daake, S., Kakehi, S., Sereni, D., Denissova, N. G., Hanlon, C., Huang, Y. J., Everett, J. K., Yin, C., Montelione, G. T., et al. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.001 · Cited by 20
Self-citationDuan, Z., Han, Y., Zhou, L., Yuan, C., Wang, Y., Zhao, C., Tang, H., & Chen, J. (2020) · Veterinary Research · doi:10.1186/s13567-020-00846-1 · Cited by 18
Insights into the nuclear export of murine leukemia virus intron-containing RNA
Pessel-Vivares, L., Houzet, L., Lainé, S., & Mougel, M. (2015) · RNA Biology · doi:10.1080/15476286.2015.1065375 · Cited by 17
Miklík, D., Šenigl, F., & Hejnar, J. (2018) · Viruses · doi:10.3390/v10030116 · Cited by 17
“Disruption of the interaction between the intasome and BET proteins or LEDGF/p75 has resulted in the decreased efficiency of retrovirus integration and retargeting outside the preferred genomic regions [12,20].”
BackgroundMethodThe N-Terminus of Murine Leukaemia Virus p12 Protein Is Required for Mature Core Stability
Wight, D. J., Boucherit, V., Wanaguru, M., Elis, E., Hirst, E. M. A., Li, W., Ehrlich, M., Bacharach, E., & Bishop, K. N. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004474 · Cited by 16
Local features determine Ty3 targeting frequency at RNA polymerase III transcription start sites
Patterson, K., Shavarebi, F., Magnan, C., Chang, I., Qi, X., Baldi, P., Bilanchone, V., & Sandmeyer, S. B. (2019) · Genome Research · doi:10.1101/gr.240861.118 · Cited by 16
“For example, MLV IN interacts with bromodomain BET proteins, BRD2, BRD3, and BRD4 associated with promoter regions (Lewinski et al. 2006; Felice et al. 2009; De Rijck et al. 2013; Aiyer et al. 2014).”
BackgroundLoyola, L. M., Achuthan, V., Gilroy, K. L., Borland, G., Kilbey, A., Mackay, N. A., Bell, M., Hay, J., Aiyer, S., Fingerman, D., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008154 · Cited by 16
“The deletion mutations that restored the BET interacting domain onto the IN-XN construct identify a linker region between the IN CTD SH3 fold (ending at KAADPG [3, 40, 57] and the IN BET interaction domain (initiating at IN W390 [4, 15]).”
BackgroundMethodInfluentialSelf-citationRelevance of BET Family Proteins in SARS-CoV-2 Infection
Lara-Ureña, N., & García‐Domínguez, M. (2021) · Biomolecules · doi:10.3390/biom11081126 · Cited by 15
Guan, R., Aiyer, S., Coté, M. L., Xiao, R., Jiang, M., Acton, T., Roth, M. J., & Montelione, G. T. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25245 · Cited by 13
Self-citationVirus–Host Interactions in Retrovirus Integration
Engelman, A. N., & Maertens, G. N. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00004-2 · Cited by 12
Applications of molecular engineering in T‐cell‐based immunotherapies
McBride, D. A., Kerr, M. D., Wai, S. L., & Shah, N. J. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1557 · Cited by 12
“Ongoing work seeks direct introduced genes away from promoter regions(Aiyer et al., 2014).”
BackgroundNKNK: a New Essential Motif in the C-Terminal Domain of HIV-1 Group M Integrases
Kanja, M., Cappy, P., Levy, N., Oladosu, O., Schmidt, S., Rossolillo, P., Winter, F., Gasser, R., Moog, C., Ruff, M., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01035-20 · Cited by 12
“3, PDB 6T6E (present study); simian immunodeficiency virus (SIV), PDB 1C6V (48); Maedi-visna virus (MVV), PDB 5LLJ (49); Rous sarcoma virus (RSV), PDB 1C0M (50); mouse mammary tumor virus (MMTV), PDB 5D7U (51); Moloney murine leukemia virus (MMLV), PDB 2M9U (52); and prototype foamy virus (PFV), PDB 4E7I (53).”
BackgroundRapid Elaboration of Fragments into Leads Applied to Bromodomain-3 Extra-Terminal Domain
Adams, L. A., Wilkinson‐White, L. E., Gunzburg, M. J., Headey, S. J., Mohanty, B., Scanlon, M. J., Capuano, B., Mackay, J. P., & Doak, B. C. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00137 · Cited by 11
Borrenberghs, D., Zurnic, I., Wit, F. D., Acke, A., Dirix, L., Cereseto, A., Debyser, Z., & Hendrix, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1157 · Cited by 11
“Using alanine scanning this residue had previously been shown to be critical for the interaction of IN with the ET domain of the BET proteins (11,17), and W390A has been shown to redistribute integration away from transcription start sites (TSS) and CpG islands (56,57).”
BackgroundInfluentialGallay, K., Blot, G., Chahpazoff, M., Yajjou, H., Confort, M.-P., de Boisséson, C., Roux, A. L., Luengo, C., Fiorini, F., Lavigne, M., et al. (2019) · Virology · doi:10.1016/j.virol.2019.04.002 · Cited by 10
Gilroy, K. L., Terry, A., Naseer, A., de Ridder, J., Allahyar, A., Wang, W., Carpenter, E. J., Mason, A. L., Wong, G. K., Cameron, E. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154070 · Cited by 9
“Moreover, FeLVs show strong conservation in the C-terminal integrase loop that in MLV has been shown to mediate interaction with BET/Brd, and this study of FeLV integration in MCF-7 breast cancer cells revealed a marked preference for transcriptional start sites and active chromatin marks similar to that PLOS ONE | DO…”
BackgroundInfluentialŠenigl, F., Miklík, D., Auxt, M., & Hejnar, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx889 · Cited by 9
“MLV integration sites are enriched within BET binding sites (6), which have been identified within actively transcribed euchromatin and characterized by specific posttranslational histone modifications (7).”
BackgroundMurine leukemia virus infection of non-dividing dendritic cells is dependent on nucleoporins
Salas-Briceno, K., Zhao, W., & Ross, S. R. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1011640 · Cited by 8
Pellaers, E., Bhat, A., Christ, F., & Debyser, Z. (2022) · Viruses · doi:10.3390/v15010032 · Cited by 8
“indicated that no reduction in the enzymatic activity of the MLV IN was observed when uncoupling the interaction with BET proteins [51].”
BackgroundMethodInfluentialRepression of the Chromatin-Tethering Domain of Murine Leukemia Virus p12
Brzezinski, J. D., Modi, A., Liu, M., & Roth, M. J. (2016) · Journal of Virology · doi:10.1128/jvi.01084-16 · Cited by 8
Self-citationKohio, H. P., Ajoge, H. O., Coleman, M. D., Ndashimye, E., Gibson, R. M., Arts, E. J., & Barr, S. D. (2023) · Viruses · doi:10.3390/v15020465 · Cited by 7
Akkawi, C., Feuillard, J., Leon-Diaz, F., Belkhir, K., Godefroy, N., Péloponèse, J., Mougel, M., & Lainé, S. (2023) · Retrovirology · doi:10.1186/s12977-023-00631-w · Cited by 6
“The IN-CTD domain contains a BET interacting domain, which guides integration targeting by tethering the pre-integration complex near transcription start sites [29, 30].”
BackgroundMoll, G. M., Swenson, C. L., & Yuzbasiyan‐Gurkan, V. (2023) · Viruses · doi:10.3390/v15091853 · Cited by 5
Nam, J.-S., Lee, J.-E., Lee, K.-H., Yang, Y., Kim, S.-H., Bae, G., Noh, H., & Lim, K. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.11.001 · Cited by 5
“In particular, MLV integrations around TSSs have been successfully reduced, but still occur at significantly high frequencies, indicating that there might be other, unknown mechanisms underlying the integration process.(20) However, searching the complete MLV integration mechanisms and finding ways to block all the cr…”
BackgroundOligomerization of Retrovirus Integrases
Grandgenett, D. P., & Aihara, H. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-10-8456-0_10 · Cited by 4
Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases
Ji, Y., Chen, W., & Wang, X. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002036 · Cited by 4
The role of chromatin in retroviral preintegration complex function
Sapp, N., Prakash, P., Chakraborty, R., Balasubramaniam, M., & Dash, C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110440 · Cited by 3
“For instance, gamma-retroviruses (MLV) and lentiviruses (HIV1/2, simian immunodeficiency virus) target nucleosomes with acetylated and methylated histones, respectively (36, 39, 80–84, 93, 110, 155, 156, 158, 159, 231, 258).”
Toward a Safer Integration Profile of MLV-based Retroviral Vectors
Schambach, A. (2014) · Molecular Therapy · doi:10.1038/mt.2014.124 · Cited by 3
Loop Plasticity Drives Paralog-Specific Recognition in BET ET Domains
ÁLVAREZ, G., Sebastian, E., Mondal, A., Roth, M. J., Montelione, G. T., & Pérez, A. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00121 · Cited by 2
Self-citationCRISPR-Cas-Based Gene Therapy to Target Viral Infections
Hussein, M., Berkhout, B., & Herrera-Carrillo, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_5 · Cited by 2
Long Terminal Repeats of Gammaretroviruses Retain Stable Expression after Integration Retargeting
Miklík, D., Slavková, M., Kučerová, D., Mekadim, C., Mrázek, J., & Hejnar, J. (2024) · Viruses · doi:10.3390/v16101518 · Cited by 2
“The BET-integrase interaction can be disrupted by single-point mutation (W390A) in integrase, allowing the development of BET-independent (Bin) γ RV vectors that are retargeted further from promoters and enhancers [26–28].”
BackgroundRetroviral Vectors for Gene Therapy of Monogenic Diseases
Yoder, K. E., Rabe, A. J., & Larue, R. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_7 · Cited by 1
Self-citationInfluence of the genomic context on integration site selection by human L1 retrotransposons
Sultana, T. (2016) · theses.fr (ABES) · doi:10.70675/be4b59d9zf7a0z4899zb1dczfce6ba9bc553 · Cited by 1
Yajjou, H. (2017) · theses.fr (ABES) · doi:10.70675/344cf9e9z00abz4537za0c2zbf6a2e27f221 · Cited by 1
Akkawi, C., Feuillard, J., Leon-Diaz, F., Belkhir, K., Godefroy, N., Péloponèse, J., Mougel, M., & Lainé, S. (2023) · Figshare · doi:10.6084/m9.figshare.24130110
Akkawi, C., Feuillard, J., Leon-Diaz, F., Belkhir, K., Godefroy, N., Péloponèse, J., Mougel, M., & Lainé, S. (2023) · Figshare · doi:10.6084/m9.figshare.24130107
Klein, F. G., Holm, P. S., & München, T. U. (2024)
Retroviral intasome architecture shapes the dynamics of target DNA search and integration
Baltierra‐Jasso, L. E., Larue, R. C., Jones, N. D., Tan, Y. Y., Messer, R. K., Ballandras-Colas, A., Engelman, A., Fishel, R. A., & Yoder, K. E. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014070
“There is no known host co-factor for either PFV or MMTV intasomes, unlike lentiviral intasomes that require LEDGF/ p75 or gamma retroviral intasomes which require Brd4 [9,10,12,43,82–86].”
Self-citationÁLVAREZ, G., Martínez‐Noa, Y., Singh, B., Gaza, J. T., Liu, Q., & Perez, A. (2026) · Wiley eBooks · doi:10.1002/9781394316632.ch07
BindingDB (2024) · UC San Diego · doi:10.7270/q23t9nkq
Metadata
- Authors
- Aiyer, S., Swapna, G. V. T., Malani, N., Aramini, J. M., Schneider, W. M., Plumb, M. R., Ghanem, M., Larue, R. C., Sharma, A., Studamire, B., Kvaratskhelia, M., Bushman, F. D., Montelione, G. T., & Roth, M. J.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- University of Pennsylvania (US)
- The Ohio State University (US)
- Brooklyn College (US)
- Corresponding author
- Montelione, Gaetano T.
- Roth, Monica J.
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-12
- Volume
- 42
- Issue
- 9
- Pages
- 5917-5928
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4027182
- OpenAlex
- W2128712095
- Cited by
- 72
- References
- 51
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 9 · 2017: 5 · 2016: 10 · 2015: 7 · 2014: 6
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion, cc-by-nc)
- Funders
- National Institutes of Health (GM094597, AI062520)
- U.S. Public Health Service (PSCOOC-40-199)
- National Institute of General Medical Sciences (R01GM070837, GM070837, GM088808, R01GM088808, GM094597, U54GM094597, SC2GM088095)
- National Institute of Allergy and Infectious Diseases (AI062520, R21AI109522, AI052845, R01AI062520, R01AI052845, P30AI045008)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- murine leukemia virus, integrase, BET proteins, BRD2, BRD3, BRD4, C-terminal tail, CpG islands, transcription start sites, gammaretroviral vectors, gene therapy safety, truncating mutations, vector targeting
- MeSH terms
- Bromodomain Containing Proteins, Amino Acid Sequence, Binding Sites, Humans, Models, Molecular, Molecular Sequence Data, Leukemia Virus, Murine, Protein Binding, Transcription Factors, Viral Proteins, RNA-Binding Proteins, Virus Integration, Sequence Deletion, Sequence Analysis, DNA, CpG Islands, Integrases, Nuclear Magnetic Resonance, Biomolecular, Transcription Initiation Site, Protein Interaction Domains and Motifs, HEK293 Cells, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.